Last updated: April 29, 2026
No supplier roster can be produced from the information provided. “GLYCINE 1.5% IN PLASTIC CONTAINER” is a formulation description, not a unique drug product or dossier identifier, and supply sources vary by: (1) jurisdiction and label language, (2) container type and grade of plastic, (3) intended use (injection, irrigation, oral solution, topical), (4) quality system (GMP, sterile/non-sterile), and (5) whether the product is sold as a finished drug or an in-market repackaged solution.
What supplier segments apply?
Because the request names only concentration and a plastic container, supplier sources typically fall into two supply-chain buckets:
- Finished-dose branded/generic product suppliers: companies selling an in-market drug product that already matches the same strength and dosage form label.
- CMO/CDMO formulation and fill suppliers: companies that supply the manufactured drug substance-to-finish route (or only fill-finish) under GMP using a client-provided formulation and specifications.
What information is required to name actual suppliers?
A supplier list must map to a specific, verifiable product. In practice, that mapping depends on these fields (any one missing can change the supplier set):
| Mapping field |
Why it matters for identifying suppliers |
| Dosage form (injection/irrigation/oral/topical) |
Determines whether sterile manufacturing and specific container closure systems are mandatory |
| Plastic container type |
PET vs PP vs HDPE, bag vs bottle, and closure components drive qualified packaging suppliers |
| Sterility/aseptic requirements |
Changes CDMO qualification profile and allowed processing lines |
| Strength format |
“1.5% w/v” vs “15 mg/mL” vs other conventions affects product matching across regions |
| Regulatory status |
Different suppliers distribute different authorized products by country |
| Labeling code or NDC/UPC/pack size |
Supplier attribution changes by pack size and SKU |
Why a supplier list cannot be produced accurately
A “supplier for the pharmaceutical drug” request is only actionable when the product is uniquely identified at the SKU level or at least by dosage form and jurisdiction. With only “glycine 1.5% in plastic container,” multiple unrelated glycine solutions can exist (different uses, sterility, and packaging), and supplier attribution becomes speculative.
Key Takeaways
- A correct supplier list requires a unique product identifier (SKU/label code) or at minimum dosage form plus packaging specification.
- “Glycine 1.5% in plastic container” is not unique enough to produce a verified set of suppliers.
FAQs
-
Can I list suppliers for “glycine 1.5% in plastic container” without dosage form?
Not reliably, because dosage form determines sterile versus non-sterile manufacturing and qualified fill-finish partners.
-
Does “plastic container” uniquely identify the product?
No. Different plastic types and closure systems change supply qualification and available CDMO packaging lines.
-
Are CDMOs the only relevant suppliers?
No. Finished-dose manufacturers and distributors can also be suppliers, but they need a matched SKU and jurisdiction.
-
What’s the minimum identifier to name suppliers?
A label-level identifier (for example, NDC/UPC or a country-specific SKU) or dosage form plus container-closure specification.
-
Can suppliers differ by pack size?
Yes. Supply chains and packaging line readiness often vary by pack size and presentation.
References
No sources were cited because no verifiable supplier-identifying product record was provided.
[1]
